Five Years of Ublituximab in Relapsing Multiple Sclerosis: Results from the OpenLabel Extension of ULTIMATE I and II Studies

Drug Category : Array
Conference Category : Array
Lead Author : Cree B, et al.
Published Date : 09/04/2025
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2025/09/AAN-2025-OLE-Encore-Cree-Final.pdf
Download Text :
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top